NEW YORK (GenomeWeb News) — AutoGenomics has hauled in $12 million through a Series C round of private-equity financing from non-institutional investors, the company said today.
 
President Fareed Kureshy said the company will use the cash to “extend our test application menu, expand manufacturing and increase our sales and marketing efforts” for its Infiniti film-based microarray system.
 
The assays are designed to help diagnose clotting disorder thrombophilia.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.